Categories: World

BRIEF-Roche Presents New Phase Iii One-Year Data For Vamikibart In Uveitic Macular Edema

Oct 10 (Reuters) – Roche Holding AG: * ROCHE PRESENTS NEW PHASE III ONE-YEAR DATA FOR VAMIKIBART IN UVEITIC MACULAR EDEMA (UME), A SERIOUS CAUSE OF VISION LOSS…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by
Published: October 11, 2026 03:14:24 IST

Oct 10 (Reuters) – Roche Holding AG: * ROCHE PRESENTS NEW PHASE III ONE-YEAR DATA FOR VAMIKIBART IN UVEITIC MACULAR EDEMA (UME), A SERIOUS CAUSE OF VISION LOSS * ROCHE HOLDING AG – VAMIKIBART

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by
Published: October 11, 2026 03:14:24 IST

Recent Posts

UPDATE 4-MLS Summaries

Oct 10 (OPTA) - Summaries for the MLS on Saturday (start times are EST) Toronto…

October 11, 2026

Cal scores with 18 seconds left to complete rally past Va. Tech

Ashten Emory scored on a 2-yard touchdown run with 18 seconds left as injury- riddled…

October 11, 2026

No. 9 Ole Miss blows out Vanderbilt, rebounds from Florida loss

Trinidad Chambliss threw three touchdown passes, Ole Miss scored four touchdowns in a nine-minute span…

October 11, 2026